← Home
🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Amgen
-8.01%
Healthcare & biotech / Biotechnology and Pharmaceuticals
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebCore Facts
CEO | Mr. Robert A. Bradway |
Employees | 28000 |
Phone | 805 447 1000 |
Address | One Amgen Center Drive Thousand Oaks 091320-1799 US |
IPO Date | 1983-06-17 |
Average Volumes | 3169012 |
Market Cap | 158.148 bil USD |
Div >7% since | N/A |
Web | https://www.amgen.com |
ISIN | US0311621009 |
NASDAQ ticker | AMGN |
News on YouTube | YouTube |
SEC | 'Amgen' on SEC |
Reports | 'Amgen' Reports |
CUSIP | 031162100 |
Wait! There's more — sign up for free or log in